Bone metastasis (BM) is the most devastating condition in patients with advanced breast cancer (BC), occurring in approximately 70% of patients, predominantly those with luminal A or estrogen/progesterone receptor‐positive (ER + /PR +) subtypes1–3. This evidence concerns the gene PGR and breast cancer.